Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Cost of Revenue (2011 - 2018)

Analysis

Cerenome (CNSY) Cost of Revenue (2011 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 489.20 Mn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 360.70 Mn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn 145.00 Mn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn 93.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn - -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 174.53 Mn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 298.26 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 67.21 Mn
10 Cerenome 20.42 Mn 11.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 628,000.00
Jun 30, 2018 630,000.00
Mar 31, 2018 579,000.00
Dec 31, 2017 633,000.00
Sep 30, 2017 487,000.00
Jun 30, 2017 707,000.00
Mar 31, 2017 716,000.00
Dec 31, 2016 945,000.00
Sep 30, 2016 618,000.00
Jun 30, 2016 585,000.00
Mar 31, 2016 567,000.00
Dec 31, 2015 791,000.00
Sep 30, 2015 502,000.00
Jun 30, 2015 1.30 Mn
Mar 31, 2015 598,000.00
Dec 31, 2014 1.42 Mn
Sep 30, 2014 337,000.00
Jun 30, 2014 766,000.00
Mar 31, 2014 421,000.00
Dec 31, 2013 1.13 Mn